2017
DOI: 10.1183/13993003.01191-2017
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxic pulmonary vasoconstriction in COPD-associated pulmonary hypertension: been there, done that?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
6
0
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
3
2
1

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 22 publications
0
6
0
1
Order By: Relevance
“…However, several pieces of evidence pointed to vascular damage as an independent process that may be previous to alveolar damage. In this respect, there are patients who develop PH prior to hypoxemia, and endothelial dysfunction with mild COPD [5][6][7]. This has also been demonstrated in the pulmonary vasculature of necropsies from healthy smokers and patients with COPD without hypoxemia and in animal models chronically exposed to tobacco smoke [8][9][10][11].…”
Section: Introductionmentioning
confidence: 79%
“…However, several pieces of evidence pointed to vascular damage as an independent process that may be previous to alveolar damage. In this respect, there are patients who develop PH prior to hypoxemia, and endothelial dysfunction with mild COPD [5][6][7]. This has also been demonstrated in the pulmonary vasculature of necropsies from healthy smokers and patients with COPD without hypoxemia and in animal models chronically exposed to tobacco smoke [8][9][10][11].…”
Section: Introductionmentioning
confidence: 79%
“…Pulmonary vascular remodeling is an important sign of COPD progression to pulmonary hypertension (11). The existing scholars believe that the pathogenesis of…”
Section: Discussionmentioning
confidence: 99%
“…This also makes us clear about the important role of inflammatory response in the process of pulmonary vascular remodeling (10). Pulmonary vascular remodeling is an important sign of COPD progression to pulmonary hypertension (11). The existing scholars believe that the pathogenesis of pulmonary hypertension is closely related to inflammation.…”
Section: Discussionmentioning
confidence: 99%
“…Hypoxic pulmonary vasoconstriction occurs in COPD patients (without COVID-19) due to reduced ventilation [51], which predisposes to in-situ thrombus formation; this pathophysiology can be worsened by COVID-19. Hypoxic pulmonary vasoconstriction is associated with increased pulmonary hypertension in COPD due to vascular remodelling [52]; again, this may be further worsened by COVID-19.…”
Section: Worse Covid-19 Clinical Outcomes In Chronic Obstructive Pulm...mentioning
confidence: 99%